Indeed, in inflammatory chronic conditions such as liver cirrhosis, idiopathic pulmonary fibrosis, and heart failure, IL-17 contributes to the severe fibrotic process through various mechanisms, including the induction of resident stromal cells and the progression of the inflammatory status. Here, IL17A is linked to pulmonary fibrosis.